J. Dai et al. / Phytochemistry 71 (2010) 2168–2173
2173
3398, 1730, 1608, 1508, 1260, 1176 cmꢀ1. For 1H (500 MHz,
MeOH-d4) and 13C (125 MHz, MeOH-d4) NMR spectroscopic data,
see Tables 1 and 2; HRESI-TOFMS obsd m/z: 709.1526 [M+Na]+,
calcd for C36H30O14Na+, 709.1533.
National Institute of Aging (R20072671). Funds for the upgrades
of the NMR instrumentation were provided by the CRIF program
of the National Science Foundation (CH E9974921) and the Elsa
Pardee Foundation. The purchase of the Agilent LC–MS was funded
by grant W911NF-04-1-0344 from the Department of Defense. We
thank T. Hemscheidt for helpful discussions regarding the biosyn-
thesis and B. Rubio for the chymotrypsin data.
4.4.5. Alkaline hydrolysis of rosmarinic acid (8)
Rosmarinic acid (100 mg) was dissolved in 10% aqueous NaOH
(5 mL) and the mixture stirred for 1 h at room temperature under
N2. The reaction mixture was passed through a DOWEX 50W-X2
column (3 ꢁ 6 cm) and eluted with H2O (200 mL). The eluate was
concentrated under reduced pressure to give a brown residue
(50 mg). The latter was then purified by RP-HPLC [Luna C8,
250 ꢁ 10 mm, a linear gradient from 5% to 10% CH3CN in H2O
(0.1% HCOOH) over 40 min, flow rate 3 mL/min, PDA and ELSD
detection] to give (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropa-
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
References
noic acid (4.2 mg) as a colorless, amorphous solid: ½a D22
ꢂ
+ 13 (c
Abbott, I.A., 1992. La’Au Hawaii: Traditional Hawaiian Uses of Plants, first ed. Bishop
Museum Press.
Arihara, S., Rüedi, P., Eugster, C.H., 1975. Dopaldehyd: erstmalige Isolierung aus
einer Pflanze in Form seines Enol–Kaffeesäureesters. Helv. Chim. Acta 58, 447–
453.
0.2, MeOH); 1H NMR (MeOH-d4) dH 2.74 (1H, dd, J = 13.8, 7.8 Hz),
2.94 (1H, dd, J = 13.8, 4.5 Hz), 4.24 (1H, dd, J = 7.8, 4.5 Hz), 6.56
(1H, dd, J = 8.1, 2.1 Hz), 6.66 (1H, d, J = 8.1 Hz), 6.71 (1H, d,
J = 2.1 Hz).
Boland, W., Mertes, K., 1985. Biosynthesis of algal pheromones. Eur. J. Biochem. 147,
83–91.
Burney, D.A., James, H.F., Burney, L.P., Olson, S.L., Kikuchi, W., Wagner, W.L., Burney,
M., McCloskey, D., Kikuchi, D., Grady, F.V., Gage, R., Nishek, R., 2001. Fossil
evidence for a diverse biota from Kaua‘i and its transformation since human
arrival. Ecol. Monogr. 71, 615–641.
Chun, M.N., Hawaii, 1994. Native Hawaiian Medicines. A New Revised and Enlarged
Translation. First People’s Productions, Honolulu, Hawaii.
Chun, M.N., Kapunihana, J.K., 1998. Native Hawaiian Medicine. First People’s
Productions, Honolulu.
Coan, K.E.D., Maltby, D.A., Burlingame, A.L., Shoichet, B.K., 2009. Promiscuous
aggregate-based inhibitors promote enzyme unfolding. J. Med. Chem. 52, 2067–
2075.
Dewick, P.M., 2002. Medicinal Natural Products: A Biosynthetic Approach, second
ed. Wiley.
4.4.6. Alkaline hydrolysis of a mixture of sebestenoid C (3) and D (4)
A mixture of sebestenoids C (3) and D (4) (6.0 mg) was dissolved
in 10% NaOH (0.5 mL) and the mixture stirred for 2 h at room tem-
perature under N2. The reaction mixture was passed through a
DOWEX 50W-X2 column (2 ꢁ 5 cm) and eluted with H2O
(100 mL). The eluate was concentrated under reduced pressure to
give a brown residue (5.0 mg). The residue was purified by RP-HPLC
[Luna C8, 250 ꢁ 10 mm, a linear gradient from 5% to 50% CH3CN in
H2O (0.1% HCOOH) over 40 min, flow rate 3 mL/min, PDA and ELSD
detection] to give (2R)-3-(3-methoxy-4-hydroxyphenyl)-2-
hydroxypropanoic acid (10, 1.1 mg) as a colorless, amorphous solid,
Eglen, R.M., 2002. Enzyme fragment complementation: a flexible high throughput
screening assay technology. Assay Drug Dev. Technol. 1, 97–104.
Euranto, E., 1977. Mechanisms and catalysis in vinyl ester hydrolysis. Pre Appl.
Chem. 49, 1009–1020.
½
a 2D2 + 13 (c 0.2, MeOH); 1H NMR (MeOH-d4) dH 2.71 (1H, dd,
ꢂ
J = 13.8, 7.8 Hz), 2.93 (1H, dd, J = 13.8, 4.2 Hz), 4.20 (1H, dd, J = 7.8,
4.2 Hz), 6.57 (1H, dd, J = 8.1, 1.6 Hz), 6.65 (1H, d, J = 8.1 Hz), 6.68
(1H, d, J = 1.6 Hz), and (2S,3S)-4-((E)-2-carboxyvinyl)-2-(3,4-dihy-
droxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carboxylic acid
Feng, B.Y., Shoichet, B.K., 2006.
A detergent-based assay for the detection of
promiscuous inhibitors. Nat. Protoc. 1, 550–553.
Grayer, R.J., Eckert, M.R., Veitch, N.C., Kite, G.C., Marin, P.D., Kokubun, T., Simmonds,
M.S., Paton, A.J., 2003. The chemotaxonomic significance of two bioactive caffeic
acid esters, nepetoidins A and B, in the Lamiaceae. Phytochemistry 64, 519–528.
Gunasekera, S.P., Miller, M.W., Kwan, J.C., Luesch, H., Paul, V.J., 2010. Molassamide, a
depsipeptide serine protease inhibitor from the marine cyanobacterium
Dichothrix utahensis. J. Nat. Prod. 73, 459–462.
Gutmanis, J., 1976. Kahuna Laau Lapaau: The Practice of Hawaiian Herbal Medicine.
Island Heritage, Aiea, Hawaii.
Hardy, J., 2006. Has the amyloid cascade hypothesis for Alzheimer’s disease been
proved? Curr. Alzheimer Res. 3, 71–73.
Kaaiakamanu, D.M., Chun, M.N., 2003. Native Hawaiian Medicine. First People’s
Productions, Honolulu, H.I., pp. 1–93.
Kaitin, K.I., 2010. Deconstructing the drug development process: the new face of
innovation. Clin. Pharmacol. Ther. 87, 356–361.
Krauss, B.H., 1993. Plants in Hawaiian Culture, first ed. University of Hawaii Press,
Honolulu.
Murata, T., Sasaki, K., Sato, K., Yoshizaki, F., Yamada, H., Mutoh, H., Umehara, K.,
Miyase, T., Warashina, T., Aoshima, H., Tabata, H., Matsubara, K., 2009. Matrix
metalloproteinase-2 inhibitors from Clinopodium chinense var. parviflorum. J.
Nat. Prod. 72, 1379–1384.
(11, 1.8 mg), as a colorless, amorphous solid, ½a D22
ꢂ
+ 137 (c 1.1,
MeOH), +168 (c 0.2, MeOH); 1H NMR (MeOH-d4) dH 4.27 (1H, d,
J = 5.1 Hz), 5.86 (1H, d, J = 5.1 Hz), 6.26 (1H, d, J = 15.9 Hz), 6.72
(1H, d, J = 8.0 Hz), 6.72 (1H, d, J = 8.0 Hz), 6.79 (1H, d, J = 2.1 Hz),
6.77 (1H, dd, J = 8.0, 2.1 Hz), 7.15 (1H, d, J = 8.0 Hz), 7.78 (1H, d,
J = 15.9 Hz); HRESI-TOFMS obsd m/z 381.0586 [M+Na]+, calcd for
C
18H14O8Na+, 381.0586.
4.4.7. Protease assay
The proteolytic cleavage of amyloid precursor protein was as-
sayed as described previously (Naqvi, 2004). Test compounds were
dissolved in DMSO at the desired concentration and incubated in
triplicate with the enzyme for 16 h in 96-well plates. A DMSO con-
Nakanishi, T., Nishi, M., Inada, A., Obata, H., Tanabe, N., Abe, S., Wakashiro, M., 1990.
Two new potent inhibitors of xanthine oxidase from leaves of Perilla frutescens
Britton var. acuta Kudo. Chem. Pharm. Bull. 38, 1772–1774.
trol (1.5 lL) and an inhibitor standard were also tested in triplicate.
The chemiluminescence signal was read using a Fluostar Optima
spectrophotometer. Data were analyzed using GraphPad Prism.
BACE1 activity was calculated as a percent of the positive control
using a nonlinear regression analysis function that corresponded
to a best one-fit model.
Naqvi, T., 2004. Galactosidase enzyme fragment complementation as
a high-
throughput screening protease technology. J. Biomol. Screen. 9, 398–408.
Neumann, C., Boland, W., 1990. Stereochemical studies on algal pheromone
biosynthesis. Eur. J. Biochem. 191, 453–459.
Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett,
F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., Regan, C.M., Walsh, D.M., Sabatini,
B.L., Selkoe, D.J., 2008. Amyloid-b protein dimers isolated directly from
Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14, 837–
842.
Acknowledgments
This work was funded by grants from the Victoria S. and Bradley
L. Geist Foundation (20070461), the Alzheimer’s Association NIRG-
08-90880, Alzheimer’s Drug Discovery Foundation (281204), the
Wada, H., Kido, T., Tanaka, N., Murakami, T., Saiki, Y., Chen, C.-M., 1992. Chemical
and chemotaxonomical studies of Ferns. LXXXI. Characteristic lignans of
Blechnaceous ferns. Chem. Pharm. Bull. 40, 2099–2101.